Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology

Human Reproduction

Volumn 26, Issue 3, 2011, Pages 604-610

  Jinno, Masao ^a   Takeuchi, Masayoshi ^b   Watanabe, Aiko ^a   Teruya, Koji ^c   Hirohama, Jun ^a   Eguchi, Noriko ^a   Miyazaki, Aiko ^d  

^a Women's Clinic Jinno   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c KYORIN UNIVERSITY   (Japan)

^d HUSHIMI Pharmatheuticals   (Japan)

Author keywords

advanced glycation end products; assisted reproductive technology; fertility; ovarian dysfunction; pregnancy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ESTRADIOL; FOLLITROPIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; PENTOSIDINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; PREGNANCY; PREGNANCY RATE;

EID: 79951571235     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq388     Document Type: Article

References (32)

1. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003;52:2110-2120. (Pubitemid 36919806)
2. Bjorntorp P, Rosmond R. The metabolic syndrome-a neuroendocrine disorder? Br J Nutr 2000;83:S49-S57.
3. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol 2005;62:37-43. (Pubitemid 40175281)
4. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 2007;127:581-589. (Pubitemid 46879051)
5. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800. (Pubitemid 28009567)
6. Eck MV, Berkhof H, Nicolson N, Sulon J. The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosom Med 1996;58:447-458. (Pubitemid 26349891)
7. Gardner DK, Schoolcraft WB. In vitro culture of human blastocyst. In: Jansen R, Mortimer D (eds). Towards reproductive certainty: Infertility and Genetics Beyond 1999. Carnforth: Parthenon Press, 1999,377-388.
8. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003;9:294-299. (Pubitemid 36362784)
9. Jinno M. Comparison of media used for human in vitro fertilization and embryo transfer programs: a new method of serum preparation. Acta Obst Gynaec Jpn 1986;38:102-110. (Pubitemid 16187735)
10. Jinno M, Kondou K, Teruya K. Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: Prediction of effectiveness by multiple parameters related to insulin resistance. Hormones (Athens) 2010;9:161-170.
11. Konishi H, Nakatsuka M, Chekir C, Noguchi S, Kamada Y, Sasaki A, Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod 2004;19:2156-2162. (Pubitemid 39236488)
12. Koyama H, Yamamoto H, Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med 2007;13:625-635. (Pubitemid 350228723)
13. Matsumine M, Shibata N, Ishitani K, Kobayashi M, Ohta H. Pentosidine accumulation in human oocytes and their correlation to age-related apoptosis. Acta Histochem Cytochem 2008;41:97-104.
14. Nakamura K, Yamagishi SI, Matsui T, Adachi H, Takeuchi M, Imaizumi T. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Clin Exp Med 2007;7:188-190.
15. Ohgi S, Nakagawa K, Kojima R, Ito M, Horikawa T, Saito H. Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome. Fertil Steril 2008;90:373-377. (Pubitemid 352040702)
16. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 1999;29:758-769. (Pubitemid 29425517)
17. Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between levels of physical training and insulin-stimulated glucose utilisation in normal humans. Diabetes 1983;32:408-411. (Pubitemid 13129958)
18. Sanaka T, Funaki T, Tanaka T, Hoshi S, Niwayama J, Taitoh T. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron 2002;91:64-73. (Pubitemid 34522834)
19. Scott RT Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
20. Scott RT, Hofmann GE, Veeck LL, Jones HW Jr, Muasher SJ. Embryo quality and pregnancy rates in patients attempting pregnancy through in vitro fertilization. Fertil Steril 1991;55:426-428.
21. Takeuchi M, Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheimers Dis 2009;16:845-858.
22. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 2000;6:114-125.
23. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, Artini PG, Piomboni P, Focarelli R. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 2008;14:131-142. (Pubitemid 351321108)
24. Terman A, Brunk UT. Aging as a catabolic malfunction. Int J Biochem Cell Biol 2004;36:2365-2375. (Pubitemid 39119752)
25. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
26. Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets 2005;6:453-474. (Pubitemid 40916272)
27. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1-21.
28. Unoki H, Yamagishi S. Advanced glycation end products and insulin resistance. Curr Pharm Des 2008;14:987-989. (Pubitemid 351753287)
29. Vanltallie TB. Stress: a risk factor for serious illness. Metabolism 2002; 51:40-45.
30. World Health Organization. WHO Laboratory Manual for Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge: Cambridge University Press, 1987,1-64.
31. Yamagishi S, Adachi H, Matsui T, Nakamura K, Takeuchi M, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y et al. Low-density lipoprotein levels are one of the independent determinants of circulating levels of advanced glycation end products in non-diabetic subjects. Clin Cardiol 2009;32:E12-E15.
32. Zhang Y, Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiol Behav 2006;88:249-256.